|
1
|
Matsuda T, Marugame T, Kamo K, Katanoda K,
Ajiki W and Sobue T; Japan Cancer Surveillance Research Group.
Cancer incidence and incidence rates in Japan in 2006: based on
data from 15 population-based cancer registries in the monitoring
of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol.
42:139–147. 2012. View Article : Google Scholar
|
|
2
|
Morrow CP, Bundy BN, Kurman RJ, Creasmann
WT, Heller P, Homesley HD and Graham JE: Relationship between
surgical-pathological risk factors and outcome in clinical stage I
and II carcinoma of the endometrium: A Gynecologic Oncology Group
Study. Gynecol Oncol. 40:55–65. 1991. View Article : Google Scholar
|
|
3
|
Creasman WT, Morrow CP, Bundy BN, Homesley
HD, Graham JE and Heller PB: Surgical pathologic spread patterns of
endometrial cancer. A Gynecologic Oncology Group Study. Cancer.
60(Suppl 8): S2035–S2041. 1987. View Article : Google Scholar
|
|
4
|
DiSaia PJ, Creasmann WT, Boronow RC and
Blessing JA: Risk factors and recurrent patterns in Stage I
endometrial cancer. Am J Obstet Gynecol. 151:1009–1015. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ishikawa M, Kitayama J, Kazama S,
Hiramatsu T, Hatano K and Nagawa H: Plasma adiponectin and gastric
cancer. Clin Cancer Res. 11:466–472. 2005.PubMed/NCBI
|
|
6
|
Wei EK, Giovannucci E, Fuchs CS, Willett
WC and Mantzoros CS: Low plasma adiponectin levels and risk of
colorectal cancer in men: a prospective study. J Natl Cancer Inst.
97:1688–1694. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mantzoros C, Petridou E, Dessypris N,
Chavelas C, Dalagama M, Alexe DM, Papadiamantis Y, Markopoulos C,
Spanos E, Chrousos G and Trichopoulos D: Adiponectin and breast
cancer risk. J Clin Endocrinol Metab. 89:1102–1107. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dal Maso L, Augustin LS, Karalis A,
Talamini R, Franceschi S, Trichopoulos D, Mantzoros CS and La
Vecchia C: Circulating adiponectin and endometrial cancer risk. J
Clin Endocrinol Metab. 89:1160–1163. 2004.PubMed/NCBI
|
|
9
|
Judd HL, Shamonki IM, Frumar AM and
Lagasse LD: Origin of serum estradiol in postmenopausal women.
Obstet Gynecol. 59:680–686. 1982.PubMed/NCBI
|
|
10
|
Berstein LM, Kvatchevskaya JO, Poroshina
TE, Kovalenko IG, Tsyrlina EV, Zimarina TS, Ourmantcheeva AF,
Ashrafian L and Thijssen JH: Insulin resistance, its consequences
for the clinical course of the disease, and possibilities of
correction in endometrial cancer. J Cancer Res Clin Oncol.
130:687–693. 2004. View Article : Google Scholar
|
|
11
|
Vona-Davis L and Rose DP: Angiogenesis,
adipokines and breast cancer. Cytokine Growth Factor Rev.
20:193–201. 2009. View Article : Google Scholar
|
|
12
|
Housa D, Housová J, Vernerová Z and
Haluzík M: Adipocytokines and cancer. Physiol Res. 55:233–244.
2006.
|
|
13
|
Garofalo C and Surmacz E: Leptin and
cancer. J Cell Physiol. 207:12–22. 2006. View Article : Google Scholar
|
|
14
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu X, Juneja SC, Maihle NJ and Cleary MP:
Leptin - a growth factor in normal and malignant breast cells and
for normal mammary gland development. J Natl Cancer Inst.
94:1704–1711. 2002. View Article : Google Scholar
|
|
16
|
Jardé T, Caldefie-Chézet F, Damez M,
Mishellany F, Perrone D, Penault-Llorca F, Guillot J and Vasson MP:
Adiponectin and leptin expression in primary ductal breast cancer
and in adjacent healthy epithelial and myoepithelial tissue.
Histopathology. 53:484–487. 2008.PubMed/NCBI
|
|
17
|
Ishikawa M, Kitayama J and Nagawa H:
Enhanced expression of leptin and leptin receptor (OB-R) in human
breast cancer. Clin Cancer Res. 10:4325–4331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tessitore L, Vizio B, Jenkins O, De
Stefano I, Ritossa C, Argiles JM, Benedetto C and Mussa A: Leptin
expression in colorectal and breast cancer patients. Int J Mol Med.
5:421–426. 2000.PubMed/NCBI
|
|
19
|
Huang L and Li C: Leptin: a
multifunctional hormone. Cell Res. 10:81–92. 2000. View Article : Google Scholar
|
|
20
|
Saxena NK, Taliaferro-Smith L, Knight BB,
Merlin D, Anania FA, O’Regan RM and Sharma D: Bidirectional
crosstalk between leptin and insulin-like growth factor-I signaling
promotes invasion and migration of breast cancer cells via
transactivation of epidermal growth factor receptor. Cancer Res.
68:9712–9722. 2008. View Article : Google Scholar
|
|
21
|
Garofalo C, Koda M, Cascio S, Sulkowska M,
Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S and Suemacz E:
Increased expression of leptin and the leptin receptor as a marker
of breast cancer progression: possible role of obesity-related
stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar
|
|
22
|
Arita Y, Kihara S, Ouchi N, Takahashi M,
Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K,
et al: Paradoxical decrease of an adipose-specific protein,
adiponectin, in obesity. 1999. Biochem Biophys Res Commun.
425:560–564. 2012.PubMed/NCBI
|
|
23
|
Bråkenhielm E, Veitonmäki N, Cao R, Kihara
S, Matsuzawa Y, Zhivotovsky B, Funahashi T and Cao Y:
Adiponectin-induced antiangiogenesis and antitumor activity involve
caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci
USA. 101:2476–2481. 2004.PubMed/NCBI
|
|
24
|
Ogunwobi OO and Beales IL: Globular
adiponectin, acting via adiponectin receptor-1, inhibits
leptin-stimulated oesophageal adenocarcinoma cell proliferation.
Mol Cell Endocrinol. 285:43–50. 2008. View Article : Google Scholar
|
|
25
|
Ishikawa M, Kitayama J, Yamauchi T,
Kadowaki T, Maki T, Miyato H, Yamashita H and Nagawa H: Adiponectin
Inhibits the growth and peritoneal metastasis of gastric cancer
through its specific membrane receptors AdipoR1 and AdipoR2. Cancer
Sci. 98:1120–1127. 2007. View Article : Google Scholar
|
|
26
|
Rzepka-Górska I, Bedner R, Cymbaluk-Płoska
A and Chudecka-Głaz A: Serum adiponectin in relation to endometrial
cancer and endometrial hyperplasia with atypia in obese women. Eur
J Gynaecol Oncol. 29:594–597. 2008.PubMed/NCBI
|
|
27
|
Yamauchi T, Kamon J, Ito Y, Tsuchida A,
Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et
al: Cloning of adiponectin receptors that mediate antidiabetic
metabolic effects. Nature. 423:762–769. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD,
Wu XP and Liao EY: Adiponectin stimulates human osteoblasts
proliferation and differentiation via the MAPK signaling pathway.
Exp Cell Res. 309:99–109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fasshauer M, Klein J, Kralisch S, Klier M,
Lössner U, Blüher M and Paschke R: Growth hormone is a positive
regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS
Lett. 558:27–32. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kharroubi I, Rasschaert J, Eizirik DL and
Cnop M: Expression of adiponectin receptors in pancreatic beta
cells. Biochem Biophys Res Commun. 312:1118–1122. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kadowaki T and Yamauchi T: Adiponectin and
adiponectin receptors. Endocrine Rev. 26:439–451. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kadowaki T, Yamauchi T, Kubota N, Hara K,
Ueki K and Tobe K: Adiponectin and adiponectin receptors in insulin
resistance, diabetes, and the metabolic syndrome. J Clin Invest.
116:1784–1792. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Takahata C, Miyoshi Y, Irahara N, Taguchi
T, Tamaki Y and Noguchi S: Demonstration of adiponectin receptors 1
and 2 mRNA expression in human breast cancer cells. Cancer Lett.
250:229–236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cong L, Gasser J, Zhao J, Yang B, Li F and
Zhao AZ: Human adiponectin inhibits cell growth and induces
apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95-2.
Endocrine Relat Cancer. 14:713–720. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gnacińska M, Małgorzewicz S, Stojek M,
Łysiak-Szydłowska W and Sworczak K: Role of adipokines in
complications related to obesity: a review. Adv Med Sci.
54:150–157. 2009.PubMed/NCBI
|
|
36
|
Hanley AJ, Bowden D, Wagenknecht LE,
Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD,
Bryer-Ash M, et al: Associations of adiponectin with body fat
distribution and insulin sensitivity in nondiabetic Hispanics and
African-Americans. J Clin Endocrinol Metab. 92:2665–2671. 2007.
View Article : Google Scholar
|
|
37
|
Petridou E, Mantzoros C, Dessypris N,
Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G and Trichopoulos
D: Plasma adiponectin concentrations in relation to endometrial
cancer: a case-control study in Greece. J Clin Endocrinol Metab.
88:993–997. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cymbaluk A, Chudecka-Głaz A and
Rzepka-Górska I: Leptin levels in serum depending on Body Mass
Index in patients with endometrial hyperplasia and cancer. Eur J
Obstet Gynecol Reprod Biol. 136:74–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Soliman PT, Wu D, Tortolero-Luna G,
Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM and Lu KH:
Association between adiponectin, insulin resistance, and
endometrial cancer. Cancer. 106:2376–2381. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cust AE, Kaaks R, Friedenreich C, Bonnet
F, Laville M, Lukanova A, Rinaldi S, Dossus L, Slimani N, Lundin E,
et al: Plasma adiponectin levels and endometrial cancer risk in
pre- and postmenopausal women. J Clin Endocrinol Metab. 92:255–263.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ashizawa N, Yahata T, Quan J, Adachi S,
Yoshihara K and Tanaka K: Serum leptin-adiponectin ratio and
endometrial cancer risk in postmenopausal female subjects. Gynecol
Oncol. 119:65–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kelesidis I, Kelesidis T and Mantzoros CS:
Adiponectin and cancer: a systemic review. Br J Cancer.
94:1221–1225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Petridou E, Mantzoros C, Dessypris N,
Dikalioti SK and Trichopoulos D: Adiponectin in relation to
childhood myeloblastic leukaemia. Br J Cancer. 94:156–160. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Goktas S, Yilmaz MI, Caglar K, Sonmez Z,
Kilic S and Bedir S: Prostate cancer and adiponectin. Urology.
65:1168–1172. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Moon HS, Chamberland J, Aronis K,
Tseleni-Balafonta S and Mantzoros C: Direct role of adiponectin and
adiponectin receptors in endometrial cancer: in vitro and ex vivo
studies in humans. Mol Cancer Ther. 10:2234–2243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Takemura Y, Osuga J, Yamauchi T, Kobayashi
M, Harada M, Hirata T, Morimoto C, Hirota Y, Yoshino O, Koga K, et
al: Expression of adiponectin receptors and its possible
implication in the human endometrium. Endocrinology. 147:3203–3210.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yamauchi N, Takazawa Y, Maeda D, Hibiya T,
Tanaka M, Iwabu M, Okada-Iwabu M, Yamauchi T, Kadowaki T and
Fukayama M: Expression levels of adiponectin receptors are
decreased in human endometrial adenocarcinoma tissues. Int J
Gynecol Pathol. 31:352–357. 2012. View Article : Google Scholar
|
